High-dose oral dexamethasone therapy for chronic childhood idiopathic thrombocytopenic purpura.
High-dose oral dexamethasone therapy for chronic childhood idiopathic thrombocytopenic purpura.
复制标题
大剂量口服地塞米松治疗慢性儿童特发性血小板减少性紫癜。
DOI：
10.1016/s0022-3476(96)70410-9
复制
发表时间：
1996
期刊：
影响因子：
--
通讯作者：
Ware,RE
中科院分区：
文献类型：
--
作者：
Adams,DM;Kinney,TR;O'Branski-Rupp,E;Ware,RE
由于大剂量口服地塞米松疗法已被报道对成人特发性血小板减少性紫癜有效，我们评估了地塞米松在7名慢性或难治性特发性血小板减少性紫癜儿童中的短期疗效和毒性。地塞米松治疗有效且耐受性良好；进一步的长期研究是有必要的。(儿科杂志1996；128：281-3)
Because high-dose oral dexamethasone therapy has been reported to be effective for adults with idiopathic thrombocytopenic purpura, we assessed the short-term efficacy and toxicity of dexamethasone in seven children with chronic or refractory idiopathic thrombocytopenic purpura. Dexamethasone therapy was effective and well tolerated; further long-term studies are warranted. (J PEDIATR 1996;128:281-3)